CFLAR and neoplasm: We demonstrate that restricting glutamine utilization in tumor cells induces a GCN2-dependent signaling pathway leading to TRAIL-R2 upregulation that together with GCN2-independent FLIP downregulation results in caspase-8 activation and apoptotic cell death.